OR WAIT null SECS
The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.
April 14, 2026
Video
Pranav discusses the necessity for addressing the structural barriers that remain for living donor kidney transplantations in black patients.
Article
A DUPLEX study investigator explains the data behind sparsentan's approval by the FDA.
April 13, 2026
FDA fully approves sparsentan for FSGS, offering the first oral non-immunosuppressive option that targets podocyte injury and cuts proteinuria.
April 10, 2026
A multicenter RCT of intradialytic cycling showed a modest, nonsignificant reduction in myocardial stunning in hemodialysis patients.
Davies explains the future of at-home dialysis access, including policy changes and technological innovation.
April 09, 2026
Catch up on nephrology headlines you missed from Q1 2026.
Davies breaks down the gaps to at-home dialysis access and the future of global collaboration.
April 08, 2026
HCPLive’s editorial team has compiled 5 of the most informative discussions, along with key data from the WCN.
2-year results from phase 3 APPLAUSE-IgAN demonstrate slower eGFR decline, reduced composite kidney failure, and proteinuria in IgAN patients treated with iptacopan.
April 07, 2026
An expert shares his perspective on emerging targets and precision strategies for podocyte injury in glomerular disease.